PE Shop Aisling Closes $280M Medical Therapies Fund
Life sciences investor Aisling Capital has closed its latest fund after taking on $280 million in committed capital that will be used to help therapeutic medicine development companies advance their products...To view the full article, register now.
Already a subscriber? Click here to view full article